Food additive mixtures commonly found in diet drinks, soups, dairy desserts and sauces may slightly increase a person's risk ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

An experimental drug may slow the progression of a form of multiple sclerosis that increases disability relentlessly, a new study finds. There are currently no FDA-approved treatments for ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Key Takeaways An experimental drug can delay disability progression in advanced multiple sclerosis patientsTolebrutinib ...

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...